{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:13:43Z","timestamp":1785410023582,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,10]]},"DOI":"10.7759\/cureus.87697","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T05:19:54Z","timestamp":1752211194000},"source":"Crossref","is-referenced-by-count":1,"title":["The Relationship Between Opioid Dose and Opioid-Induced Constipation in Japanese Patients With Cancer Pain: A Post Hoc Analysis of a Prospective Observational Cohort Study"],"prefix":"10.7759","author":[{"given":"Soichi","family":"Fumita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Koretaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102704","article-title":"Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: a systematic review and meta-analysis","volume":"125","author":"Kistemaker KR","year":"2024","unstructured":"Kistemaker KR, Sijani F, Brinkman DJ, de Graeff A, Burchell GL, Steegers MA, van Zuylen L. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: a systematic review and meta-analysis. Cancer Treat Rev. 2024, 125:102704. 10.1016\/j.ctrv.2024.102704","journal-title":"Cancer Treat Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-023-00520-2","article-title":"A nationwide hospital claims database analysis of real-world patterns of laxative use for opioid-induced constipation in Japanese patients with cancer","volume":"12","author":"Higashibata T","year":"2023","unstructured":"Higashibata T, Kessoku T, Morioka Y, et al.. A nationwide hospital claims database analysis of real-world patterns of laxative use for opioid-induced constipation in Japanese patients with cancer. Pain Ther. 2023, 12:993-1003. 10.1007\/s40122-023-00520-2","journal-title":"Pain Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5056\/jnm23144","article-title":"Opioid-induced constipation: old and new concepts in diagnosis and treatment","volume":"30","author":"Squeo F","year":"2024","unstructured":"Squeo F, Celiberto F, Ierardi E, et al.. Opioid-induced constipation: old and new concepts in diagnosis and treatment. J Neurogastroenterol Motil. 2024, 30:131-42. 10.5056\/jnm23144","journal-title":"J Neurogastroenterol Motil"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2341","article-title":"Incidence of opioid-induced constipation in Japanese patients with cancer pain: a prospective observational cohort study","volume":"8","author":"Tokoro A","year":"2019","unstructured":"Tokoro A, Imai H, Fumita S, et al.. Incidence of opioid-induced constipation in Japanese patients with cancer pain: a prospective observational cohort study. Cancer Med. 2019, 8:4883-91. 10.1002\/cam4.2341","journal-title":"Cancer Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement","volume":"7","author":"Farmer AD","year":"2019","unstructured":"Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O'Brien T, Morlion B, Tack J. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United European Gastroenterol J. 2019, 7:7-20. 10.1177\/2050640618818305","journal-title":"United European Gastroenterol J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002024","article-title":"Opioid-induced constipation in patients with cancer: a \"real-world,\" multicentre, observational study of diagnostic criteria and clinical features","volume":"162","author":"Davies A","year":"2021","unstructured":"Davies A, Leach C, Butler C, et al.. Opioid-induced constipation in patients with cancer: a \"real-world,\" multicentre, observational study of diagnostic criteria and clinical features. Pain. 2021, 162:309-18. 10.1097\/j.pain.0000000000002024","journal-title":"Pain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy148","article-title":"Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines","volume":"29","author":"Larkin PJ","year":"2018","unstructured":"Larkin PJ, Cherny NI, La Carpia D, Guglielmo M, Ostgathe C, Scott\u00e9 F, Ripamonti CI. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018, 29:iv111-25. 10.1093\/annonc\/mdy148","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2019.11.021","article-title":"Patients' self-assessment of the symptoms and impact of opioid-induced constipation: results from a prospective observational cohort study of Japanese patients with cancer","volume":"59","author":"Fumita S","year":"2020","unstructured":"Fumita S, Imai H, Harada T, et al.. Patients' self-assessment of the symptoms and impact of opioid-induced constipation: results from a prospective observational cohort study of Japanese patients with cancer. J Pain Symptom Manage. 2020, 59:1043-1051.e2. 10.1016\/j.jpainsymman.2019.11.021","journal-title":"J Pain Symptom Manage"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2019.0487","article-title":"Opioid-induced constipation in chronic pain: experience with 180 patients","volume":"15","author":"Vel\u00e1zquez Rivera I","year":"2019","unstructured":"Vel\u00e1zquez Rivera I, Vel\u00e1zquez Clavarana L, Garc\u00eda Velasco P, Melero Ramos C. Opioid-induced constipation in chronic pain: experience with 180 patients. J Opioid Manag. 2019, 15:69-76. 10.5055\/jom.2019.0487","journal-title":"J Opioid Manag"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy118","article-title":"Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer","volume":"29","author":"Katakami N","year":"2018","unstructured":"Katakami N, Harada T, Murata T, et al.. Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer. Ann Oncol. 2018, 29:1461-7. 10.1093\/annonc\/mdy118","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2015.19","article-title":"Genetic and non-genetic factors associated with constipation in cancer patients receiving opioids","volume":"6","author":"Laugsand EA","year":"2015","unstructured":"Laugsand EA, Skorpen F, Kaasa S, Sabatowski R, Strasser F, Fayers P, Klepstad P. Genetic and non-genetic factors associated with constipation in cancer patients receiving opioids. Clin Transl Gastroenterol. 2015, 6:e90. 10.1038\/ctg.2015.19","journal-title":"Clin Transl Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04996-7","article-title":"More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer","volume":"28","author":"Roeland EJ","year":"2020","unstructured":"Roeland EJ, Sera CJ, Ma JD. More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer. Support Care Cancer. 2020, 28:1793-7. 10.1007\/s00520-019-04996-7","journal-title":"Support Care Cancer"},{"key":"ref13","unstructured":"Rome Foundation. Rome IV criteria (C6 opioid-induced constipation). (2021). Accessed: June 15, 2025: https:\/\/theromefoundation.org\/rome-iv\/rome-iv-criteria\/."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.300.6722.439","article-title":"Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate","volume":"300","author":"O'Donnell LJ","year":"1990","unstructured":"O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ. 1990, 300:439-40. 10.1136\/bmj.300.6722.439","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/147323001103900106","article-title":"The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients","volume":"39","author":"Ueberall MA","year":"2011","unstructured":"Ueberall MA, M\u00fcller-Lissner S, Buschmann-Kramm C, Bosse B. The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients. J Int Med Res. 2011, 39:41-50. 10.1177\/147323001103900106","journal-title":"J Int Med Res"},{"key":"ref16","article-title":"WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Accessed April 9, 2025","year":"2019","unstructured":"WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. World Health Organization, Geneva, Switzerland; 2019. https.\/\/www.who.int\/publications\/i\/item\/9789241550390."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2021.0438","article-title":"Revision of pharmacological treatment recommendations for cancer pain: clinical guidelines from the Japanese Society of Palliative Medicine","volume":"25","author":"Mawatari H","year":"2022","unstructured":"Mawatari H, Shinjo T, Morita T, Kohara H, Yomiya K. Revision of pharmacological treatment recommendations for cancer pain: clinical guidelines from the Japanese Society of Palliative Medicine. J Palliat Med. 2022, 25:1095-114. 10.1089\/jpm.2021.0438","journal-title":"J Palliat Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2011.563236","article-title":"Naloxone as part of a prolonged release oxycodone\/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers","volume":"20","author":"Smith K","year":"2011","unstructured":"Smith K, Hopp M, Mundin G, et al.. Naloxone as part of a prolonged release oxycodone\/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers. Expert Opin Investig Drugs. 2011, 20:427-39. 10.1517\/13543784.2011.563236","journal-title":"Expert Opin Investig Drugs"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00381","article-title":"Naldemedine for opioid-induced constipation in patients with cancer: a multicenter, double-blind, randomized, placebo-controlled trial","volume":"42","author":"Hamano J","year":"2024","unstructured":"Hamano J, Higashibata T, Kessoku T, et al.. Naldemedine for opioid-induced constipation in patients with cancer: a multicenter, double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2024, 42:4206-17. 10.1200\/JCO.24.00381","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002746","article-title":"Efficacy and safety of naldemedine for opioid-induced constipation in older patients with cancer: a retrospective study","volume":"36","author":"Imai H","year":"2024","unstructured":"Imai H, Fujita Y, Hiruta E, et al.. Efficacy and safety of naldemedine for opioid-induced constipation in older patients with cancer: a retrospective study. Eur J Gastroenterol Hepatol. 2024, 36:571-7. 10.1097\/MEG.0000000000002746","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-022-07002-9","article-title":"Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis","volume":"30","author":"Kanbayashi Y","year":"2022","unstructured":"Kanbayashi Y, Ishizuka Y, Shimizu M, Sawa S, Yabe K, Uchida M. Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis. Support Care Cancer. 2022, 30:5831-6. 10.1007\/s00520-022-07002-9","journal-title":"Support Care Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09154-w","article-title":"Efficacy of prophylactic laxatives against opioid-induced constipation: retrospective propensity score matching analysis","volume":"33","author":"Okuda Y","year":"2025","unstructured":"Okuda Y, Kuriyama T, Tsukiyama Y, Shimokawa T, Wan K, Kawamata T. Efficacy of prophylactic laxatives against opioid-induced constipation: retrospective propensity score matching analysis. Support Care Cancer. 2025, 33:115. 10.1007\/s00520-025-09154-w","journal-title":"Support Care Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2016.0331","article-title":"Identifying factors that predict worse constipation symptoms in palliative care patients: a secondary analysis","volume":"20","author":"Clark K","year":"2017","unstructured":"Clark K, Lam LT, Talley NJ, Phillips JL, Currow DC. Identifying factors that predict worse constipation symptoms in palliative care patients: a secondary analysis. J Palliat Med. 2017, 20:528-32. 10.1089\/jpm.2016.0331","journal-title":"J Palliat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/365263-the-relationship-between-opioid-dose-and-opioid-induced-constipation-in-japanese-patients-with-cancer-pain-a-post-hoc-analysis-of-a-prospective-observational-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T05:19:55Z","timestamp":1752211195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/365263-the-relationship-between-opioid-dose-and-opioid-induced-constipation-in-japanese-patients-with-cancer-pain-a-post-hoc-analysis-of-a-prospective-observational-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.87697","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}